Wutah pendapatan taun lumaku: Quoin Pharmaceuticals (QNRX)

Logo perusahaan publik Quoin Pharmaceuticals Ltd. (QNRX)

Quoin Pharmaceuticals is developing a unique therapy system for rare skin pathologies, offering alternative-free treatment methods for ichthyosis. The company is scaling its business through partnerships with global distributors, accelerating the market launch of innovative gels. Meanwhile, management is optimizing patient workflows under conditions of limited capital. The current year-over-year (TTM) revenue growth rate shows that the metric remains at 0.00.

Wutah dodolan YoY sajrone rolas wulan kepungkur: quoinpharma.com (QNRX) kanggo 11.02.2024 - 19.11.2026

Ringkesan rincian data analitis Quoin Pharmaceuticals Ltd (QNRX)

- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:quoinpharma.com
Produk merek Quoin Pharmaceuticals Ltd.

Investors are seeking objective scaling markers in Quoin Pharmaceuticals (QNRX) financial reports, utilizing revenue dynamics over the last twelve months to filter out market noise. By analyzing the annual sales growth rate on a TTM basis, one can assess the effectiveness of strategic distribution alliances for rare dermatological drugs, where a steady acceleration of this metric confirms the successful commercialization of clinical developments and the expansion of the brand's market presence.